Long-term ingestion of Touchi-extract, an α-glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reaven, 1988, Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595
De Fronzo, 1991, Insulin resistance a multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atheroscrelotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173
Toeller, 1994, α-glucosidase inhibitors in diabetes, Eur J Clin Invest, 24, 31, 10.1111/j.1365-2362.1994.tb02253.x
Clissold, 1988, Preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential, Drugs, 35, 214, 10.2165/00003495-198835030-00003
Saito, 1998, Effect of an α -glucosidase inhibitor (voglibose), in combination with sulphonilureas, on glycaemic control in type 2 diabetes subjects, J Int Med Res, 26, 219, 10.1177/030006059802600501
Rury, 1999, A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycaemic control over 3 years (U.K Prospective Diabetes Study 44), Diabetes Care, 22, 960, 10.2337/diacare.22.6.960
Fujita, 2000, Classification and antihypertensive activity of angiotensin I-converting enzyme derived from food proteins, J Food Sci, 65, 564, 10.1111/j.1365-2621.2000.tb16049.x
Matsui, 1996, In vitro survey of α-glucosidase inhibitory food components, Biosci Biotechnol Biochem, 60, 2019, 10.1271/bbb.60.2019
Watanabe, 1997, Isolation and identification of α-glucosidase inhibitors from Tochu-cha (Encommia ulmoides), Biosci Biotechnol Biochem, 61, 177, 10.1271/bbb.61.177
Hansawasdi, 2000, α-amylase inhibitors from Rosell (Hibiscus sabdariffa Linn) Tea, Biosci Biotechnol Biochem, 64, 1041, 10.1271/bbb.64.1041
Morimoto, 1999, Effects of long-term ingestion of wheat albumin in mild non-insulin-dependent diabetes mellitus, J Jpn Soc Nutr Food Sci (in Japanese), 52, 293, 10.4327/jsnfs.52.293
Fujita, 2001, Fermented soybean-derived touchi extract with anti-glycaemic effect via α-glucosidase inhibitory action in rats and humans, J Nutr, 131, 1211, 10.1093/jn/131.4.1211
Fujita, 2001, Efficacy and Safety of Touchi Extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insuline-dependent diabetic mellitus, J Nutr Biochem, 12, 351, 10.1016/S0955-2863(01)00149-8
Fujita, 2001, Fermented soybean-derived touchi-extract with anti-diabetic effect via α-glucosidase inhibitory action in a long-term administration study with KKAy mice, Life Sci, 70, 219, 10.1016/S0024-3205(01)01381-9
Miwa, 1986, Inhibition of intestinal α-glucosidases and sugar absorption by flavones, Chem Pharm Bull, 34, 838, 10.1248/cpb.34.838
1997, Expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183
1993
Hillerbrand, 1979, The effects of the α -glucosidase inhibitor BAY g5421 (acarbose) on meal stimulated elevations of circulating glucose, insulin and triglyceride levels in man, Res Exp Med, 175, 81, 10.1007/BF01851236
Hillerbrand, 1979, The effects of the α-glucosidase inhibitor BAY g5421 (acarbose) on postprandial glucose, serum insulin and triglyceride levels, Res Exp Med, 175, 87, 10.1007/BF01851237
Homma, 1982, Changes in plasma lipoprotein levels during medication with a glucosidase-hydrolase inhibitor (acarbose), Tokai Journal of Experimental and Clinical Medicine, 7, 393
Nestel, 1985, Lower triglyceride production during carbohydrate-rich diet through acarbose, α-glucosidase hydrolase inhibitor, Diabete et Metabolism, 11, 316
Harano, 2002, Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular disease, J Diabetes and its Complications, 16, 19, 10.1016/S1056-8727(01)00192-1
Malaguarnera, 1998, Beneficial effects of acarbose on familiar hypertriglyceridemias, Clin Pharmacol Ther, 36, 441
Matsuo, 1992, Effect of an intestinal disaccharidase inhibitor (AO-128), on obesity and diabetes, Am J Clin Nutr, 55, 314, 10.1093/ajcn/55.1.314s